Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 27;22(3):40.
doi: 10.3892/br.2024.1918. eCollection 2025 Mar.

Mechanism of PI3K/Akt‑mediated mitochondrial pathway in obesity‑induced apoptosis (Review)

Affiliations
Review

Mechanism of PI3K/Akt‑mediated mitochondrial pathway in obesity‑induced apoptosis (Review)

Jiarui Li et al. Biomed Rep. .

Abstract

Obesity is a pervasive global health challenge that substantially reduces the quality of life of millions of individuals and impedes social and economic advancement. Obesity is an independent risk factor that contributes to a range of chronic non-communicable metabolic diseases, significantly affecting energy metabolism, mental health, cancer susceptibility, sleep quality, and other physiological processes. The PI3K/AKT signaling pathway, a significant glucose, lipid, and protein metabolism regulator, is integral to cellular growth, survival, and apoptosis. Apoptosis is a highly regulated form of programmed cell death that is critical for immune cell maturation and tissue repair. The present review examines the association between obesity, the PI3K/AKT pathway, and mitochondrial apoptosis to elucidate the potential mechanisms by which obesity may activate apoptotic pathways. These findings provide a theoretical foundation for mitigating obesity-related complications by targeting these critical pathways.

Keywords: PI3K/AKT signaling pathway; apoptosis; mitochondrial pathway; obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Mechanism of apoptosis regulation in the mitochondrial pathway by PI3K/AKT. IGF-1R, insulin-like growth factor 1 receptor; GPCR, G-protein coupled receptor; BCR, B-cell receptor; VEGFR, vascular endothelial growth factor receptor; TCR, T-cell receptor; EGFR, epidermal growth factor receptor; IRS-1, insulin receptor substrate 1; PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol (3,4,5)-triphosphate; AKT, protein kinase B; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein; Bad, Bcl-2-associated death promoter; Cyt c, cytochrome c, Apaf-1, apoptotic protease activating factor 1; caspase-9, cysteinyl aspartate specific protease 9; caspase-3, cysteinyl aspartate specific protease 3. (Created in BioRender. Li, J. (2024) https://BioRender.com/y00e363).
Table II
Table II
Structures of active components of Traditional Chinese medicine and their effects on the PI3K/AKT pathway and apoptosis.

References

    1. Gustafson B, Nerstedt A, Smith U. Reduced subcutaneous adipogenesis in human hypertrophic obesity is linked to senescent precursor cells. Nat Commun. 2019;10(2757) doi: 10.1038/s41467-019-10688-x. - DOI - PMC - PubMed
    1. Kivimäki M, Strandberg T, Pentti J, Nyberg ST, Frank P, Jokela M, Ervasti J, Suominen SB, Vahtera J, Sipilä PN, et al. Body-mass index and risk of obesity-related complex multimorbidity: An observational multicohort study. Lancet Diabetes Endocrinol. 2022;10:253–263. doi: 10.1016/S2213-8587(22)00033-X. - DOI - PMC - PubMed
    1. Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387:1377–1396. doi: 10.1016/S0140-6736(16)30054-X. NCD Risk Factor Collaboration (NCD-RisC) - DOI - PMC - PubMed
    1. Chen K, Shen Z, Gu W, Lyu Z, Qi X, Mu Y, Ning Y. Prevalence of obesity and associated complications in China: A cross-sectional, real-world study in 15.8 million adults. Diabetes Obes Metab. 2023;25:3390–3399. doi: 10.1111/dom.15238. Meinian Investigator Group. - DOI - PubMed
    1. Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, et al. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(138) doi: 10.1186/s12943-023-01827-6. - DOI - PMC - PubMed

LinkOut - more resources